Last quarter (Q2 2023), Fusion Antibodies Plc's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Fusion Antibodies Plc's net income was $―. See Fusion Antibodies Plc’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Total Revenue	$ ―	$ 1.14M	$ 2.90M	$ 4.80M	$ 4.17M	$ 3.90M
Cost of Revenue	$ ―	$ 1.18M	$ 2.33M	$ 2.33M	$ 2.14M	$ 2.12M
Gross Profit	$ ―	$ -45.00K	$ 574.00K	$ 2.47M	$ 2.02M	$ 1.77M
Operating Expense	$ ―	$ 2.25M	$ 3.43M	$ 3.81M	$ 3.27M	$ 2.83M
Operating Income	$ ―	$ -2.29M	$ -2.90M	$ -1.35M	$ -1.25M	$ -1.06M
Net Non Operating Interest Income Expense	$ ―	$ -2.00K	$ -1.00K	$ -8.00K	$ 15.00K	$ 14.00K
Other Income Expense	$ ―	$ ―	$ -11.00K	$ ―	$ ―	$ ―
Pretax Income	$ ―	$ -2.29M	$ -2.86M	$ -1.33M	$ -1.26M	$ -1.07M
Tax Provision	$ ―	$ -63.00K	$ -263.00K	$ -133.00K	$ 1.64M	$ -376.00K
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ ―	$ -2.23M	$ -2.60M	$ -1.20M	$ -2.90M	$ -697.00K
Basic EPS	$ ―	$ -0.04	$ -0.10	$ -0.05	$ -0.11	$ -0.03
Diluted EPS	$ ―	$ -0.04	$ -0.10	$ -0.05	$ -0.11	$ -0.03
Basic Average Shares	$ ―	$ 55.56M	$ 26.01M	$ 25.95M	$ 25.46M	$ 22.09M
Diluted Average Shares	$ ―	$ 55.56M	$ 26.01M	$ 25.95M	$ 25.61M	$ 22.09M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ ―	$ 3.43M	$ 5.76M	$ ―	$ -5.41M	$ -4.95M
Net Income From Continuing And Discontinued Operation	$ ―	$ -2.23M	$ -2.60M	$ -1.20M	$ -2.90M	$ -697.00K
Normalized Income	$ ―	$ -2.36M	$ -3.12M	$ -1.47M	$ -1.02M	$ -1.45M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ ―	$ -2.28M	$ -2.85M	$ -1.32M	$ -1.25M	$ -1.05M
EBITDA	$ ―	$ -2.06M	$ -2.48M	$ -573.00K	$ -532.00K	$ -1.05M

Currency in USD

Fusion Antibodies Plc Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing